Beyond Air Shares Outstanding 2016-2021 | XAIR

Beyond Air shares outstanding from 2016 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Beyond Air Annual Shares Outstanding
(Millions of Shares)
2021 18
2020 12
2019 8
2017 6
2016 1
2016
2015 1
2015
Beyond Air Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 22
2021-03-31 18
2020-12-31 18
2020-09-30 17
2020-06-30 17
2020-03-31 15
2019-12-31 11
2019-09-30 11
2019-06-30 9
2019-03-31 9
2018-12-31 9
2018-09-30 8
2018-06-30 8
2018-03-31
2017-12-31
2017-09-30 6
2017-06-30 6
2017-03-31 6
2016-12-31
2016-09-30 1
2016-06-30 2
2016-03-31 2
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.279B $0.001B
Beyond Air Inc. is a clinical-stage medical device and biopharmaceutical company. It is engaged in developing a Nitric Oxide Generator and Delivery System. The company's principal product is AirNOvent which is in clinical stage. Beyond Air Inc., formerly known as AIT Therapeutics Inc., is based in Garden City, New York.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29